Phlow was formed to manufacture low-cost, high quality, essential drugs for the United States.

To help our nation secure its own strategic drug reserve, Phlow will use novel and innovative methods in the drug manufacturing industry to support our customers, including the U.S. government and to reduce the U.S.’s dependency on foreign supply chains.

Executive Leadership

Our team has unmatched experience in research, development and commercialization of API, pharmaceuticals, and medical device products. Not only does our team have a deep understanding of the challenges of building world-class products and facilities, but we also recognize that quality, efficiency and affordability of medicines is paramount to a stable health care system.

Eric Edwards, M.D., Ph.D.

Chief Executive Officer

View Biography

Patricia Watson, M.S.

Vice President, Regulatory Affairs

View Biography

Andrew Stiles

Vice President, Government Initiatives
and Contract Compliance

View Biography

Robby Demeria

Chief of Staff

View Biography

Glenn Gerecke, Ph.D.

Chief Operating Officer

View Biography

Wayne Motsek

Vice President, Quality Assurance

View Biography

J. Robert Mooney

Chief Financial Officer

View Biography

Malcolm Rosenthal, M.B.A.

Vice President, Business Development 

View Biography

BOARD OF DIRECTORS

Eric Edwards, MD PhD.

Co-Founder & CEO

Learn More

Dr. Frank Gupton, PhD.

Co-Founder & CEO, Medicines for All

Learn More

Martin Van Trieste

President & CEO, Civica Rx

Learn More

Marshall L. Summar, MD

Strategic Advisor and Member of the Board

Learn More

Rosemary Gibson

Strategic Advisor and Member of the Board

Learn More

OUR PARTNERS

Civica Logo
Learn More
Medicines for All Institute and VCU College of Engineering Logo
Learn More
Ampac Fine Chemicals Logo
Learn More

News and Media

Learn More

Contact Us

Reach Out